See also this year's filing and all EDGAR filings for this company.
PDF Report 0001763950_2026_Lantern_Pharma_Inc.pdf
Logs
Graph
Absolute values for 0001763950, Lantern Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,803,172 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 31,875 |
| 3 | remainder_Assets | 200,764 |
| 4 | LiabilitiesCurrent | 4,501,587 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,323,793 |
| 9 | ResearchAndDevelopmentExpense | 10,204,920 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 955,818 |
| 13 | remainder_ComprehensiveNetIncome | -14,394 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,035,811 |
| 1 | Liabilities | 4,501,587 |
| 2 | Expenses | 16,528,713 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 6,534,224 |
| 5 | NetIncome | -15,572,895 |
| 6 | ComprehensiveNetIncome | -15,580,092 |
| 7 | BaseVar | 16,518,162 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.172 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
